These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7321933)

  • 21. Early skin response to fractionated doses of pions for determining therapeutic gain factors.
    Ohizumi Y; Lam GK; Pickles T; Chaplin DJ
    Tokai J Exp Clin Med; 1996 Jun; 21(2):69-75. PubMed ID: 9239808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxygenation and blood flow in tumors treated with hydralazine: evaluation with a novel luminescence-based fiber-optic sensor.
    Jarm T; Sersa G; Miklavcic D
    Technol Health Care; 2002; 10(5):363-80. PubMed ID: 12368557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combined effect of Paclitaxel and ionizing radiation. Experimental data of in-vitro and in-vivo models].
    Rübe C; Hampel G; Schuck A; Willich N
    Strahlenther Onkol; 1996 May; 172 Suppl 1():2-5. PubMed ID: 8633269
    [No Abstract]   [Full Text] [Related]  

  • 24. Hypoxia-selective 3-alkyl 1,2,4-benzotriazine 1,4-dioxides: the influence of hydrogen bond donors on extravascular transport and antitumor activity.
    Hay MP; Pchalek K; Pruijn FB; Hicks KO; Siim BG; Anderson RF; Shinde SS; Phillips V; Denny WA; Wilson WR
    J Med Chem; 2007 Dec; 50(26):6654-64. PubMed ID: 18052317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EPR oximetry of tumors in vivo in cancer therapy.
    Sentjurc M; Cemazar M; Sersa G
    Spectrochim Acta A Mol Biomol Spectrosc; 2004 May; 60(6):1379-85. PubMed ID: 15134738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect on regrowth delay in a murine tumor of scheduling split-dose irradiation based on direct pO2 measurements by electron paramagnetic resonance oximetry.
    O'Hara JA; Goda F; Demidenko E; Swartz HM
    Radiat Res; 1998 Nov; 150(5):549-56. PubMed ID: 9806597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cisplatin and radiotherapy: towards a new therapeutic system?].
    Reboul F; Vincent P; Serin D; Alfonsi M; Plat F
    Bull Cancer Radiother; 1990; 77(2):95-100. PubMed ID: 8703552
    [No Abstract]   [Full Text] [Related]  

  • 28. Cellular heterogeneity in malignant tumors. The importance of clonal interaction on tumor evolution, response to chemotherapy and metastatic ability evaluated in experimental systems.
    Aabo K
    Dan Med Bull; 1996 Sep; 43(4):336-49. PubMed ID: 8884135
    [No Abstract]   [Full Text] [Related]  

  • 29. Improvement of tumor oxygenation status by mild temperature hyperthermia alone or in combination with carbogen.
    Song CW; Shakil A; Griffin RJ; Okajima K
    Semin Oncol; 1997 Dec; 24(6):626-32. PubMed ID: 9422259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of differential radiosensitization of hypoxic cells in a mouse tumor at low radiation doses per fraction by cisplatin.
    Sun JR; Brown JM
    Radiat Res; 1993 Feb; 133(2):252-6. PubMed ID: 8438067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 induction and apoptosis in response to radio- and chemotherapy in vivo is tumor-type-dependent.
    Kemp CJ; Sun S; Gurley KE
    Cancer Res; 2001 Jan; 61(1):327-32. PubMed ID: 11196181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination treatment of murine tumors by adenovirus-mediated local B7/IL12 immunotherapy and radiotherapy.
    Lohr F; Hu K; Haroon Z; Samulski TV; Huang Q; Beaty J; Dewhirst MW; Li CY
    Mol Ther; 2000 Sep; 2(3):195-203. PubMed ID: 10985949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiation-induced DNA damage in tumors and normal tissues. I. Feasibility of estimating the hypoxic fraction.
    Zhang H; Wheeler KT
    Radiat Res; 1993 Oct; 136(1):77-88. PubMed ID: 8210342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human solid tumors.
    Guilbaud N; Kraus-Berthier L; Meyer-Losic F; Malivet V; Chacun C; Jan M; Tillequin F; Michel S; Koch M; Pfeiffer B; Atassi G; Hickman J; Pierré A
    Clin Cancer Res; 2001 Aug; 7(8):2573-80. PubMed ID: 11489841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mathematical modeling of oxygen diffusion and consumption in malignant tumor].
    Knigavko VG; Bondarenko MA
    Biofizika; 2005; 50(3):544-9. PubMed ID: 15977846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ursolic acid-induced changes in tumor growth, O2 consumption, and tumor interstitial fluid pressure.
    Lee I; Lee J; Lee YH; Leonard J
    Anticancer Res; 2001; 21(4A):2827-33. PubMed ID: 11724362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Augmentation of antitumor activity of an antibody-interleukin 2 immunocytokine with chemotherapeutic agents.
    Holden SA; Lan Y; Pardo AM; Wesolowski JS; Gillies SD
    Clin Cancer Res; 2001 Sep; 7(9):2862-9. PubMed ID: 11555604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of hemoglobin levels on tumor oxygenation: the higher, the better?
    Vaupel P; Mayer A; Höckel M
    Strahlenther Onkol; 2006 Feb; 182(2):63-71. PubMed ID: 16447012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of oxygen tension in tumours by time-resolved fluorescence.
    Young WK; Vojnovic B; Wardman P
    Br J Cancer Suppl; 1996 Jul; 27():S256-9. PubMed ID: 8763892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of bioactive additive mammoleptin on development of transplanted tumors in mice.
    Zueva EP; Naumova EM; Valentinov BG; Amosova EN; Razina TG; Krylova SG; Shilova NV; Gol'dberg VE
    Bull Exp Biol Med; 2000 Dec; 130(12):1150-2. PubMed ID: 11276307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.